Literature DB >> 2251604

Chronic laxative abusers with pseudo-idiopathic oedema and autonomous pseudo-Bartter's syndrome. A spectrum of metabolic madness, or new lights on an old disease?

A M Meyers1, C Feldman, M I Sonnekus, D T Ninin, L P Margolius, N A Whalley.   

Abstract

The numerous metabolic abnormalities encountered in chronic purgative abusers were investigated and the new concept of autonomous pseudo-Bartter's syndrome documented. Detailed metabolic screening tests were performed in 9 women aged 17-54 years. Two patients underwent further studies, including serum renin and aldosterone, blood volume, total body potassium, urinary chloride and prostaglandin determinations, and each underwent renal biopsy on admission and after 1 year free from laxative abuse. Clinical complications included confusion, convulsions, coma, skeletal muscle weakness with or without paralysis or rhabdomyolysis, cardiac failure, urinary tract infections and bone disease (osteomalacia, secondary hyperparathyroidism and osteoporosis). Hypokalaemia, hypomagnesaemia, hypocalcaemia and hypophosphataemia were frequent findings. Serum creatine kinase correlated inversely with the product of the potassium and serum phosphate (r = -0.86; P less than 0.03), suggesting that hypokalaemia and hypophosphataemia act synergistically to produce muscle damage. After laxative withdrawal, oedema and weight gain, followed by diuresis, ensued in 7 patients. In the other 2, ongoing chloruresis, kaliuresis, hyper-reninaemia and raised urinary prostaglandin secretion persisted. Renal biopsies in these 2 patients showed the features of juxtaglomerular apparatus hyperplasia as well as medullary interstitial cell hyperplasia. In conclusion, pseudo-Bartter's syndrome was documented in 9 chronic laxative abusers. Because patients often indulged in more than one aberrant habit, e.g. laxative and/or diuretic abuse or bulimia, the clinical syndrome produced a myriad of confounding metabolic derangements, which we termed 'metabolic madness'. Laxative withdrawal was complicated by temporary pseudo-idiopathic oedema, which persisted in 2 patients. Further studies in these 2 women strongly supported the concept of 'autonomous pseudo-Bartter's syndrome'.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251604

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

1.  Abuse/misuse of non-prescription drugs.

Authors:  G F Hughes; J C McElnay; C M Hughes; P McKenna
Journal:  Pharm World Sci       Date:  1999-12

2.  Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals.

Authors:  Elena Ramírez; Tomás Rossignoli; Armando J Campos; Raúl Muñoz; Claudia Zegarra; Hoi Tong; Nicolás Medrano; Alberto M Borobia; Antonio J Carcas; Jesús Frías
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

3.  Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study.

Authors:  Glenda F Fleming; James C McElnay; Carmel M Hughes
Journal:  Pharm World Sci       Date:  2004-10

Review 4.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Diuretics-assisted treatment of chronic laxative abuse.

Authors:  Yuichi Shirasawa; Michio Fukuda; Genjiro Kimura
Journal:  CEN Case Rep       Date:  2014-03-26

6.  Autopsy report on pseudo-Bartter syndrome with renal calcification induced by diuretics and diet pills.

Authors:  Kana Unuma; Akihiro Tojo; Kazuki Harada; Kanju Saka; Makoto Nakajima; Takeshi Ishii; Toshiro Fujita; Ken-Ichi Yoshida
Journal:  BMJ Case Rep       Date:  2009-05-25

7.  Oral acyclovir induced hypokalemia and acute tubular necrosis a case report.

Authors:  Jonathan S Chávez-Iñiguez; Ramón Medina-Gonzalez; Lilia Aguilar-Parra; Eduardo J Torres-Vázquez; Pablo Maggiani-Aguilera; Enrique Cervantes-Pérez; Guillermo García-García
Journal:  BMC Nephrol       Date:  2018-11-14       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.